All contracts that are issued, delivered or renewed on or after January 1, 2024 for a third party that reimburses for 340B drugs shall not do any of the following:
1. Discriminate in reimbursement on the basis that the pharmacy dispenses a 340B drug.
2. Assess any fee, chargeback, clawback or adjustment on the basis that a pharmacy dispenses a 340B drug.
3. Exclude a pharmacy from a third party's pharmacy network on the basis that the pharmacy dispenses a 340B drug.
4. Restrict the methods or pharmacies within a third-party network by which a 340B covered entity may dispense or deliver 340B drugs.